CL vs CLX

Key Takeaways

• CL is the larger, more globally diversified business, with emerging-market and pet-nutrition momentum offsetting softer U.S. demand.
• CLX is navigating a major portfolio transition, including the GOJO (Purell) acquisition and an ERP (enterprise resource planning) system rollout that distorted recent comparisons.
• Colgate-Palmolive has delivered consistent organic sales growth and trades at a premium forward valuation, while Clorox carries a higher dividend yield at a lower multiple.
• Clorox has shown stronger short-term price momentum, but its 52-week return remains deeply negative, whereas Colgate has been more stable.
• Analyst consensus is more constructive on CL (average "Buy") than on CLX (average "Hold"), though both carry meaningful upside to price targets.
• The two names offer contrasting risk profiles: Colgate favors steady compounding, while Clorox is a turnaround-and-integration story.

Introduction

Colgate-Palmolive (CL) and The Clorox Company (CLX) are two of the most recognized names in U.S. consumer staples, yet they sit at very different stages of their corporate lifecycles. Colgate is a diversified oral-care and pet-nutrition leader reporting steady growth, while Clorox is executing a strategic pivot around health and hygiene after acquiring the Purell brand. This stock comparison is relevant to traders and investors weighing stability against turnaround potential, income against valuation, and global diversification against a more concentrated U.S. portfolio. Understanding their relative performance, market positioning, and catalysts can help clarify which profile better fits a given investment objective in the current market environment.

CL Overview and Recent Performance

Colgate-Palmolive is a global consumer products company best known for its oral-care franchise, holding a leading position in toothpaste and manual toothbrushes worldwide, alongside Hill's Pet Nutrition and a portfolio of personal-care brands. In recent quarters, the company has posted steady results driven by emerging markets such as India, Brazil, Mexico, and China, where organic sales (sales growth excluding currency, acquisitions, and divestitures) has remained positive. In its most recent reported quarter, net sales rose roughly 5% year over year, and gross margin expanded on pricing, favorable mix, and productivity programs.

The main soft spot has been North America, where volume has declined amid retail destocking and competitive pressure. In recent weeks, management has also been reported to be exploring a sale of certain mass-market personal-care brands, including Softsoap, Irish Spring, and Speed Stick, signaling a sharper focus on higher-growth categories. Colgate raised its dividend earlier in the year, reflecting confidence in cash generation. The stock has been relatively stable versus the broader consumer staples sector, supported by its low beta and geographic reach.

CLX Overview and Recent Performance

The Clorox Company is a U.S.-centric maker of cleaning, household, and lifestyle products, including its namesake bleach, Glad, Kingsford, Hidden Valley, Burt's Bees, Brita, and Fresh Step. Clorox is in the middle of a multi-year transformation: it completed its acquisition of GOJO Industries (maker of Purell) and finished a five-year U.S. ERP (enterprise resource planning) implementation, which is a system for integrating business processes and data. Those events created difficult year-over-year comparisons, because retailers had pulled forward shipments before the system transition, temporarily inflating prior results.

For its most recent fiscal year, Clorox reported lower net sales and earnings versus the prior year, with gross margin pressured by higher commodity, manufacturing, and logistics costs. Despite this, the stock rallied meaningfully in recent weeks as investors looked past the comparison noise toward the company's outlook, which calls for a return to sales growth aided by GOJO and eventual ERP-driven productivity gains. The shares still trade well below their 52-week high, however, reflecting an uncertain demand and margin recovery path.

Trending AI Robots

Tickeron maintains hundreds of AI trading bots that collectively trade thousands of different tickers across diverse strategies, timeframes, and risk profiles. Because no single bot suits every market environment, Tickeron curates only the strongest performers into a dedicated Trending AI Robots section. These bots vary widely in trading style, from swing and trend-following approaches to shorter-term momentum systems, each with its own performance history, win rate, and set of traded tickers. This curated selection is designed to help traders identify the bots most aligned with current market conditions rather than sifting through the full catalog. Explore the Trending AI Robots page to review the latest statistics and find a bot that matches your trading approach.

Head-to-Head Comparison

The clearest contrast is scale and diversification. Colgate generates tens of billions in annual revenue across more than 200 countries and territories, giving it meaningful exposure to faster-growing emerging markets. Clorox is smaller and more concentrated in the U.S., with a heavier reliance on a handful of categories and brands. Colgate's growth is largely organic and consistent; Clorox's near-term growth is heavily dependent on acquisition contributions and lapping prior-year comparison effects.

Valuation and income also diverge. Colgate trades at a premium forward P/E (price-to-earnings) multiple in the low-to-mid 20s and pays a dividend yield of roughly 2.5%. Clorox trades at a lower forward multiple in the low teens but offers a substantially higher yield, around 6%, reflecting greater perceived execution risk and elevated debt following the GOJO deal. On momentum, Clorox has rallied sharply off recent lows, while Colgate has drifted modestly lower from its highs. Risk profiles differ too: Colgate's low beta suggests defensive stability, whereas Clorox's larger 52-week decline and integration workload introduce more uncertainty. Sentiment, as reflected in analyst ratings, is more favorable toward Colgate.

Tickeron AI Verdict

Based on observable factors such as trend consistency, stability, and relative positioning, Tickeron's AI would likely tilt toward CL as the steadier candidate in the current environment. Colgate's diversified revenue base, recurring organic growth, healthy margins, and constructive analyst consensus point to a more consistent trend profile. In contrast, CLX offers higher income and a potentially larger turnaround catalyst, but its path depends on successful integration, margin recovery, and a rebound in underlying demand—factors that introduce greater variability. The AI's preference would therefore be probabilistic and conditional rather than definitive, with Colgate favored for consistency and Clorox favored mainly for investors willing to accept higher volatility in pursuit of yield and a recovery narrative.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations